*|MC:SUBJECT|*
bioRN News December 2025
Dear *|FNAME|* *|LNAME|*,

The year is drawing to a close and, before we bring you the latest updates from 2025, we would like to take a moment to express our sincere thanks to you:

THANK YOU for your commitment to our vibrant life science ecosystem.
We hope that you have been able to gain valuable information and inspiration from the bioRN Newsletters 2025 to help you initiate new business opportunities and learn more about our activities.

We look forward to meeting you in person soon at one of the many networking and knowledge-sharing events in 2026. 
We wish you a peaceful Christmas season and a good start to 2026,
kind regards
the bioRN Team with: 
Julia Schaft, Malika Fennech, Nicole Hecht, Stephanie Füller, Friedemann Loos, Arantxa Encinas-López, Daniela Weber, Alexya Azhakesan, Ursula Volk and Michelle Sommer. 

bioRN News and Updates December 2025:

2 December: bioRN M2M Member to Member featuring Just Evotec Biologics:
The last bioRN M2M Member to Member interview of the year was held with Nick Hutchinson, Associate VP Business Development of Just Evotec Biologics about their integrated platform and the innovative J.POD® concept. Whatch the video here.

11 December: bioRN Members’ Assembly with election of a new Executive Board:
This year´s General Members´Assembly at the Tanktum in Heidelberg reflected on a year shaped by transformation, collaboration and growing impact across the Rhine-Neckar life science ecosystem. Read about bioRN's activities in our annual report.
With the new elected Executive Board members bioRN strengthens expertise in digitalisation, entrepreneurship, translational research and pharma R&D. Find the press release here:

Meet bioRN in January and February 2026:

1)  22- 23 January, 11:30am:  PRECISEU Meetup Best Practice Champions 2025 - learn more about the winning projects Genomcore and ENGAGE ATMP and OPORA Health and PragmaTIL, 
Register here.
2) 03 February, 6pm, KLINKER Café Heidelberg: C-Level-Circle hosted by WMT AG
3) 04 February, 8-8pm, Heidelberg Congress Center: life - the biomedical convention
Register here.
4) 24 February, 7pm, Urban Kitchen: bioRN Lounge featuring Dr. Philipp Kuhn, Yumab:  Next-generation TCR-like antibodies with improved specificity profiles

Be part of life - the bioRN Life Science Cluster magazine - No. 2/2026
With life – the bioRN Life Science Magazine – we present impressive stories from the region, both digitally and in print. The first issue was published in October and is distributed by the bioRN team at events and trade fairs to increase the visibility of our ecosystem at the European level. The next issue is planned for October 2026 – again in collaboration with European Biotechnology Magazine and promoted at BIO Europe 2026. We are already starting the initial editorial preparations. If you would like to contribute, please contact sf@biorn.org.

Don´t miss further news from the network at the bioRN website.
Find out about new bioRN events here and get the latest news about funding and growth opportunities at 05 | Opportunities.

We wish you a a peaceful Advent season!

Kind regards,

Stephanie Füller 
PR Manager
bioRN Life Science Cluster 
LinkedIn
Twitter
Website
01 | Research Highlights & News
02 | New Members
03 | Event Spotlights
04 | Event Calendar & Discounts
05 | Opportunities
06 | Open Positions
01 | Research Highlights & News

BioRN: BioRN strenghthens its Leadership and Governance to reflect a growing life science ecosystem [more] 

Heidelberg University
 Outstanding Placings in Shanghai Ranking of Academic Subjects [more] 

Heidelberg University Hospital: 
  • It’s now official: the alliance between the two university hospitals in Heidelberg and Mannheim can start as planned on January 1 and begin its work.
    [more] 
  • Cystic fibrosis research: AI-assisted evaluation of MRI images in chronic rhinosinusitis 
    [more]
Max Planck Institute for Medical Research: 
New Research Group Leader at the Max Planck Institute for Medical Research [more]

Hopp Children´s Cancer Center (KITZ): AI-supported molecular cancer diagnosis for brain tumors [more]

EMBL: 
VIRE: a global data platform to better understand viruses  [more]

DKFZ: 
AI-generated social media content as an opportunity for cancer prevention [more]

 

02 | New Members


More information about the new members and other bioRN members can be found here.
CARMA FUND is an early-stage investment fund for advancing Life Science and Healthcare technologies. The fund started off in June 2022 and has €56M under management. It is based in Munich and Frankfurt am Main.CARMA FUND I is uniquely suited for young companies and projects from the Life Science and medical space due to an extra-long term, flexible investment modes and its close relationships with leading technology transfer offices and industry partners. 
Emerging Pharma Discovering (EPD) Consulting empowers researchers and founders to turn  scientific discoveries into investor - ready, clinically driven programs. We help early drug developers align science, strategy and execution to avoid costly misstepsm, reduce risk and increase the chances of clinical success, 
GEN H  Gen-H’s team of scientists has extensive experience in genetic engineering, gained through daily application of Red/ET recombination (also known as recombineering). This technology, originally developed at the EMBL in Heidelberg, allows precise, scarless modification of DNA. Gen-H offers proprietary technologies, including an antibiotic-free plasmid maintenance system and optimized bacterial strains. In addition, Gen-H offers its expertise in genetic engineering to academic and industrial clients in fee-for-service projects.
Histomography provides easy access to 3D tissue data at subcellular resolution, granting unparalleled insights into the structure and function of biological tissue. With Histomography, you can benefit from quantitative and automated analysis, unlocking endless possibilities. Histomography offers a tissue-retaining x-ray technique that can be effortlessly integrated into your histological workflow for paraffin-embedded samples.Unlike conventional histology, there is no need for staining. Plus, because it's non-destructive, it is compatible with conventional histological analysis.
Valuse Laboratory Instruments  focuses on development and production of tools for research laboratories, aiming to enable researchers to increase their niche applications speed and robustness.With VariPrep Valuse Laboratory Instrumentshttps://www.valuse-instruments.de/ offers a solution for MALDI Matrix Application which is 5x faster than a common glass sublimator.

03 | Event Spotlights

04 | Event Calendar & Discounts
PRECISEU Meet Up Best Practice Recognition Champions 2025 
22 January 2026, 11:30 am – 1 pm (CET): Genomcore and ENGAGE ATMP (register here) 
23 January 2026, 11:30 am – 1 pm (CET): OPORA Health and PragmaTIL (register here) 
life - the biomedical convention
4 February 2026, 8-8pm: (register here) 
Complimentary conference tickets for bioRN members.
Workshop: Learn from Experts – Maximize the Potential of Your Cell-Based Assays!
March 04-05, 2026 - Walldorf, Germany >>
15 % discount for members.
 
health.tech global summit
March 02-05, 2026 - Basel, Switzerland >>
10 % discount for members & opportunity for start-Up partnering!
 
Aktuelle Trends im Biomanufacturing
March 11-12, 2026 - Stuttgart, Germany >>

 
Bio-Europe Spring
March 23-25, 2026 - Lisbon, Portugal >>
10 % discount for members.
 
LSX World Congress Europe 2026
25-26 March, 2026 - Lisbon, Portugal >>
10 % discount for members.
 
German Biotechnology Days
April 21-22, 2026 - Leipzig, Germany >>

 
SaxoCell Conference 2026
June 02-03, 2026 - Dresden, Germany >>
20 % discount for members.
 

05 | Opportunities

In this section we provide selected information on funding calls and events. On our website in the section startup support you will find a calendar with all opportunities 
 

Open Calls:  

Transnationale Forschungsprojekte innerhalb der Europäischen Partnerschaft One Health Antimicrobial Resistance zu Kombinationstherapien und Therapieadhärenz. more 

Pitches: 
Landespreis BW: Vorbilder, die neue Wege gehen. more

Knowledge Transfer: 
4C Accelerator: kostenloses Qualifizierungsprogramm für Medizinprodukte, Software als Medizinprodukt und In-vitro-Diagnostik more

GeneNovate: Empowering Innovators and Entrepreneurs in Gene and Cell Therapies. Online participation options more

Closings: 
  • Volve Capital closes its first €9 million fund to back tech founders at the earliest stages - Volve Capital, more



 

06 | Open Positions
 

BioMed X Institute in New Haven, Connecticut, USA

  • ​Group Leader / Postdoctoral Researchers / Research Assistants [more]

PROGEN:

  • Operations & Events Executive (m/w/d) – Heidelberg, Germany [more]
  • Strategic Account Manager (m/f/d) – Heidelberg, Germany [more]
  • Stellvertretende Herstellungsleitung (m/w/d) – Heidelberg, Germany [more]
Tweet Tweet
Forward Forward
Share Share

Imprint


Copyright © *|CURRENT_YEAR|* *|LIST:COMPANY|*, All rights reserved.
*|IFNOT:ARCHIVE_PAGE|* *|LIST:DESCRIPTION|*

Responsible for the content:
Dr. Julia Schaft

Editor: Stephanie Füller

Our mailing address is:
*|HTML:LIST_ADDRESS_HTML|* *|END:IF|*

Commercial Register: Mannheim, HRB 704801
VAT ID: DE 2630 64 014

unsubscribe from this list    update subscription preferences 

*|IF:REWARDS|* *|HTML:REWARDS|* *|END:IF|*